DSM's Route Scouting & Implementation of Synthetic Processes Is A Cost-effective Solution For Commercialization

DMS offers shorter and more efficient scale up of chemistries—speeding development and reducing costs.

Emerging pharma companies that have projects with high potential and biotechs with small molecule projects need a sustainable manufacturer with the resources and expertise to partner with them all the way to commercialization. DSM's capabilities in route design and implementation of synthetic processes across our facilities make us an ideal full service partner.

DSM has developed a methodology for cost-effective solutions to optimize your investment. We employ an interdisciplinary approach across pharmaceutical chemistry and biotechnology in the area of route scouting, where we identify the ideal synthesis routes for commercial production of active pharmaceutical ingredients. Our process encompasses biocatalysis, homogenous catalysis, and micro reactor technology.

We are a financially-stable, large independent company with a wealth of in-house expertise and experience across pharmaceutical chemicals and biologics, peerless quality systems and technologies, and an exceptional reputation with regulatory bodies that significantly eases licensing and CMC filing procedures.